Sophia Hober

USPTO Granted Patents = 12 (Patent Applications = 4)

CIPO Patents = 1

EPO Patents = 5 (Patent Applications = 10)

Average Co-Inventor Count = 1.5

ph-index = 9

Forward Citations = 205(Granted Patents)

Company Filing History:

5 out of 371

Ge Healthcare Bio-sciences Ab

Cytiva Bioprocess R&d Ab

patents

4. 1 out of 43

Ge Healthcare Bioprocess R&d Ab

patents

5. 1 out of 135

Ge Healthcare Bio-sciences Corp.

patents

6. 1 out of 1

Ge Health Bio-sciences Ab

patent

Years Active: 2004-2023

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11820802 - Ligand and use thereof (2023-11-21),

2. 11505576 - Polypeptides based on a scaffold (2022-11-22),

3. 10918971 - Mutated immunoglobulin-binding protein (2021-02-16),

4. 9534023 - Mutated immunoglobulin-binding protein (2017-01-03),

5. 9296791 - Mutant protein (2016-03-29),

6. 9156892 - Mutated immunoglobulin-binding protein (2015-10-13),

7. 8916689 - Method for labeling of compounds (2014-12-23),

8. 8354510 - Mutant protein (2013-01-15),

9. 8198404 - Mutated immunoglobulin-binding protein (2012-06-12),

10. 7834158 - Mutated immunoglobulin-binding protein (2010-11-16),

11. 7709209 - Protein ligands (2010-05-04),

12. 6831161 - Method of affinity separation and ligands for use therein (2004-12-14),

Title: Sophia Hober - Innovative Inventor from Stockholm

Introduction: Sophia Hober is a pioneering inventor based in Stockholm, Sweden, known for her groundbreaking contributions to the field of biotechnology.

Latest Patents: Sophia Hober holds several patents in the area of protein engineering and biotechnology, with her most recent patent focusing on a novel method for protein purification.

Career Highlights: With a career spanning over two decades, Sophia Hober has made significant advancements in the development of protein-based therapeutics, earning her recognition as a leading expert in the field.

Collaborations: Throughout her career, Sophia Hober has collaborated with top research institutions and biopharmaceutical companies to further the application of her innovative technologies in the healthcare industry.

Conclusion: Sophia Hober's dedication to innovation and her relentless pursuit of scientific excellence continue to inspire the next generation of inventors and researchers in the field of biotechnology.

This text is generated by artificial intelligence and may not be accurate.